# BIVI catalysts: BIOVIE INC. PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/bivi/catalysts

> BIOVIE INC. (BIVI) has no upcoming catalysts in this calendar. The latest recorded is the bezisterim topline data readout, Aug to Nov 2026.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: half-year only, exact day, quarter only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Company

| Field | Value |
| --- | --- |
| Name | BIOVIE INC. |
| Ticker | BIVI (Nasdaq) |
| SEC CIK | 1580149 |
| SIC | 2834 |
| SEC filings | https://sec-api.dev/companies/bivi |

## Cash runway

Cash $7.7M as of 2026-09-30; quarterly burn $2.9M; about 8.0 months of runway at that rate (XBRL company facts, accession 0001520138-26-000461).

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| 1H 2026 | [BIOVIE INC. topline data readout](https://sec-api.dev/companies/bivi/catalysts) | BIVI |  | scheduled | "Topline results from the trial are expected in the first half of 2026." ([SEC Form 10-Q](https://www.sec.gov/Archives/edgar/data/1580149/000152013826000052/bivi-20251231_10q.htm)) |
| May 1, 2026 | [Bezisterim primary completion](https://sec-api.dev/pdufa/bezisterim) | BIVI | Parkinsons Disease (PD) | completed | "NCT06757010 (A Study of NE3107 in Early Parkinson's): Overall Status COMPLETED; Phase PHASE2; Primary Completion 2026-05-01 (ACTUAL); Lead Sponsor BioVie Inc.." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06757010)) |
| August 6, 2026 | [Bezisterim primary completion](https://sec-api.dev/pdufa/bezisterim) | BIVI | Long COVID | completed | "NCT06847191 (NE3107 in Adults With Neurological Symptoms of Long COVID): Overall Status COMPLETED; Phase PHASE2; Primary Completion 2026-08-06 (ACTUAL); Lead Sponsor BioVie Inc.." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06847191)) |
| Aug to Nov 2026 | [Bezisterim topline data readout](https://sec-api.dev/pdufa/bezisterim) | BIVI | Long COVID | scheduled | "NCT06847191 (NE3107 in Adults With Neurological Symptoms of Long COVID): Overall Status COMPLETED; Phase PHASE2; Primary Completion 2026-08-06 (ACTUAL); Lead Sponsor BioVie Inc.." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06847191)) |

## Drugs

- [Bezisterim](https://sec-api.dev/pdufa/bezisterim): Long COVID, Parkinsons Disease (PD)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/bivi/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "BIVI catalysts: BIOVIE INC. PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/bivi/catalysts

```bibtex
@misc{secapidev_companies_bivi_catalysts_20261116,
  title        = {BIVI catalysts: BIOVIE INC. PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/bivi/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_bivi_catalysts_20261116","title":"BIVI catalysts: BIOVIE INC. PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/bivi/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
